Ananda presenting at Master Investor Show

Ananda Developments PLC
26 February 2024
 

26 February 2024

 

ANANDA DEVELOPMENTS PLC

 

("Ananda" or the "Company")

 

Ananda presenting at Master Investor Show

 

Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, is pleased to announce that certain Directors of the Company will be attending and speaking at the Master Investor Show in London at The Business Design Centre 52 Upper Street London N1 0QH on Saturday, the 9th of March. Ananda will be present all day at booth M:19 and will be presenting on the Showcase Stage at 10.30 a.m.

 

The Company will be represented at the event by its CEO Melissa Sturgess and the Company's Finance director Jeremy Sturgess-Smith.

 

Ananda's CEO, Melissa Sturgess commented: "We look forward to meeting and talking with interested parties, shareholders, potential shareholders and stakeholders at the conference."

 

To register for the Master Investor Show, please use the following link: https://masterinvestorshow-2024.reg.buzz/?exhibitor-inviter=18f1c1fa-b9ee-11ee-9af7-000000000000

 

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

  

·              Investor Hub: investors.anandadevelopments.com

·              Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=   

·              LinkedIn: https://www.linkedin.com/company/anadevelopments/   

·              Twitter: https://twitter.com/AnandaPlc

·              Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

 

-Ends-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information please contact:

InvestorHub

Engage with us directly at Ananda Developments Investor Hub

 

Sign up at investors.anandadevelopments.com

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess


Executive Director

Jeremy Sturgess-Smith

 

+44 (0)7463 686 497 ir@anandadevelopments.com

SP ANGEL CORPORATE FINANCE LLP

Corporate Finance

Richard Morrison

Harry Davies-Ball

+44 (0)20 3470 0470

Corporate Broking

Abigail Wayne

Rob Rees

 


Yellow Jersey PR

Charles Goodwin

Soraya Jackson

+44 (0)20 3004 9512

 

 

About Ananda Developments

Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based

medicines for the treatment of complex, chronic inflammatory pain conditions.

 

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/.

https://investors.anandadevelopments.com/link/0PQ09r

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings